- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A sponsored symposium recording about Lixiana was uploaded to Vimeo with incorrect privacy settings, making it viewable by the public. Breach found…
A health professional complained about a Chiesi asthma webinar. The Panel found breaches for unreadable/too-brief prescribing information and describing Trimbow as “safe”.…
A creative agency posted Itulazax (POM) campaign frames on Instagram after the contract ended. Panel found a Clause 3.2 breach, but the…
Ex-employee alleged a post-ASH ‘scientific exchange’ was disguised promotion. Panel found meeting non-promotional but ruled breaches for high standards (misleading terminology) and…
A third-party web contractor inadvertently removed APO-go prescribing information during remediation work, leaving PI inaccessible for over 24 hours. PMCPA ruled a…
Novo Nordisk admitted certification failures for a password-protected obesity/weight management hub hosted on an association website. Panel found poor oversight and ruled…
Four Novartis-funded Leqvio (inclisiran) supplement articles were accessible without the landing page and omitted the black triangle; printed versions appeared to lack…
HSJ “sponsored” article on AF/stroke was not clear at the outset that it was written by a senior Daiichi Sankyo employee. Breach…
AstraZeneca was ruled in breach of Clause 8.1 after the Forxiga diabetes webpage differed between desktop and mobile (audience banner shown on…
A Ferinject promotional article in the British Journal of Cardiology used “safe” in key messages without adequate qualification. Breach of Clause 7.9…
Amgen-sponsored webinar invite and downloadable infographic looked like they were from an independent organisation. Sponsorship disclosure appeared too late and wording was…
A US Kerendia (finerenone) DTC banner campaign was inadvertently accessible on MailOnline in the UK. The Panel found it was promotional POM…
Complaint alleged Forxiga ‘Prescribing & Dosing’ webpage omitted “critical” SPC warnings for moderate renal impairment (PTH increase, hypotension). Panel ruled no breach…
Complaint alleged repeated brand-name use and patient-record style questions in Abilify Maintena ATU tracking market research (2018–2021). PMCPA Panel found the activity…
A former creative agency posted about past work and referenced Emerade on social media. PMCPA ruled the agency was not a third…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.